← SynDRA
AZD-8055
SynDRA canonical compound SYN0027361 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | MTOR |
| Mechanism of action | MTOR inhibitor |
All known targets
Mechanisms of action (all sources)
- MTOR inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
Cross-references
Synonyms
- AZD 8055
- AZ-12600000
- AZD8055
- [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
- (5-(2,4-bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol
- UNII-970JJ37FPW
- 970JJ37FPW
- CHEMBL1801204
- AK109550
- (5-(2,4-Bis((S)-3-methylmorpholino)pyrido-[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol
- (5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol
- [5-[2,4-bis((3s)-3-methylmorpholin -4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
- (5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol.
- (5-{2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl}-2-methoxyphenyl)methanol
- [5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
- MLS006010169
- SCHEMBL298416
- GTPL7714
- CHEBI:91329
- EX-A044
- AZD 8055 [WHO-DD]
- DTXSID001020704
- AMY24189
- BCP02171
- EX-A1549
- BDBM50348452
- MFCD16660191
- NSC758871
- NSC799351
- s1555
- ZINC52509466
- AKOS016009126
- BCP9000367
- CCG-264912
- CS-0067
- DB12774
- NSC-758871
- NSC-799351
- SS-4787
Look up AZD-8055 in the interactive SynDRA portal →